F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence
Status:
Completed
Trial end date:
2021-03-19
Target enrollment:
Participant gender:
Summary
This study evaluates the diagnostic performance and safety of F-18-PSMA-1007 and
F-18-Fluorocholine PET/CT imaging in patients with suspected recurrence of prostate cancer
after previous definitive treatment.